![R. Scott Olson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
R. Scott Olson
Algemeen Directeur bij Secretory IgA, Inc.
Profiel
R.
Scott Olson is the founder of Secretory IgA, Inc. Prior to that, he worked as a Principal at Unitech Pharmaceuticals, Inc. He holds an MBA from the University of Michigan.
Actieve functies van R. Scott Olson
Bedrijven | Functie | Begin |
---|---|---|
Secretory IgA, Inc.
![]() Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Algemeen Directeur | - |
Eerdere bekende functies van R. Scott Olson
Bedrijven | Functie | Einde |
---|---|---|
Unitech Pharmaceuticals, Inc.
![]() Unitech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Unitech Pharmaceuticals, Inc. operates as a pharmaceutical research company. It engages in the discovery and development of novel treatments for a variety of autoimmune diseases and cancer. It operates as a pharmaceutical research company. The company was founded in 1994 by Jiajiu Shaw and is located in Ann Arbor, MI | Corporate Officer/Principal | - |
Opleiding van R. Scott Olson
University of Michigan | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Secretory IgA, Inc.
![]() Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Health Technology |
Unitech Pharmaceuticals, Inc.
![]() Unitech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Unitech Pharmaceuticals, Inc. operates as a pharmaceutical research company. It engages in the discovery and development of novel treatments for a variety of autoimmune diseases and cancer. It operates as a pharmaceutical research company. The company was founded in 1994 by Jiajiu Shaw and is located in Ann Arbor, MI | Health Technology |